A 1% annual fee doesn't cost you 1% — it costs you 1% compounded over your entire investing life, because every dollar taken in fees is also a dollar that never compounds again. Over 40 years, the difference between a 0.05% index fund and a 1.5% actively managed fund can consume roughly a third of your final balance, even if both earn identical gross returns.
What makes this worse is that higher fees don't buy better results. The evidence is overwhelming that the large majority of actively managed funds underperform their benchmark index over long periods, and the ones that outperform in one period rarely repeat it — past performance genuinely doesn't predict future performance. Fees, meanwhile, are the one variable you can control with certainty. This is the core argument for low-cost broad-market index funds: you can't control returns, but you can guarantee you keep more of them.
Since 2002, S&P Dow Jones Indices has published the SPIVA scorecard, which does something the fund industry had avoided: systematically compares actively managed funds against their appropriate benchmark, correcting for survivorship bias by including funds that closed or merged away. The results have been remarkably consistent across decades and countries. Over 15- and 20-year horizons, roughly 85–95% of active US equity funds underperform their benchmark index. The funds that do beat the index in one period show little persistence — SPIVA's companion 'Persistence Scorecard' repeatedly finds that top-quartile funds rarely stay top-quartile. John Bogle, who founded Vanguard and launched the first index fund available to retail investors in 1976 (mocked at the time as 'Bogle's folly'), had argued exactly this: in a market where you can't reliably pick winners, the surest way to improve returns is to stop paying for the attempt.